<bill session="117" type="s" number="1723" updated="2023-03-08T20:12:49Z">
  <state datetime="2021-05-20">REFERRED</state>
  <status>
    <introduced datetime="2021-05-20"/>
  </status>
  <introduced datetime="2021-05-20"/>
  <titles>
    <title type="display">Budgeting for Opioid Addiction Treatment Act</title>
    <title type="official" as="introduced">A bill to amend the Internal Revenue Code of 1986 to establish a stewardship fee on the production and importation of opioid pain relievers, and for other purposes.</title>
    <title type="short" as="introduced">Budgeting for Opioid Addiction Treatment Act</title>
  </titles>
  <sponsor bioguide_id="M001183"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2021-05-20"/>
    <cosponsor bioguide_id="B001277" joined="2021-05-20"/>
    <cosponsor bioguide_id="H001076" joined="2021-05-20"/>
    <cosponsor bioguide_id="K000383" joined="2021-05-20"/>
    <cosponsor bioguide_id="K000367" joined="2021-05-20"/>
    <cosponsor bioguide_id="R000615" joined="2021-05-20"/>
    <cosponsor bioguide_id="S001181" joined="2021-05-20"/>
    <cosponsor bioguide_id="S001203" joined="2021-05-20"/>
    <cosponsor bioguide_id="W000817" joined="2021-05-20"/>
    <cosponsor bioguide_id="W000802" joined="2021-05-20"/>
  </cosponsors>
  <actions>
    <action datetime="2021-05-20">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-05-20" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Congressional oversight"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health care coverage and access"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Long-term, rehabilitative, and terminal care"/>
    <term name="Prescription drugs"/>
    <term name="Sales and excise taxes"/>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary date="2021-07-08T14:04:40Z" status="Introduced in Senate">Budgeting for Opioid Addiction Treatment Act 

This bill imposes an excise tax on the sale of any active opioid. The tax is equal to one cent per milligram so sold and it is imposed on the manufacturer, producer, or importer of the opioid. The term active opioid means any controlled substance that is opium, an opiate, or any derivative thereof.

The bill provides block grants for substance abuse treatment programs.

The Department of Health and Human Services must report on the impact of this bill on (1) the retail cost of active opioids; (2) patient access to such opioids, particularly cancer and hospice patients; and (3) the use of tax revenues to improve substance abuse treatment efforts. The report must also make suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.</summary>
</bill>
